The analysis estimated cervical cancer screening coverage among women aged 30-49 worldwide. Three in five had never been screened by any method. Some 92% had never had an HPV test, the high-performance test on which the elimination strategy rests. Coverage varied substantially between regions and between country-income levels. Both figures sit well below WHO's target of screening 70% of women. The coverage figures come from a synthetic analysis rather than direct measurement in every country.
Why it is interesting: Separates HPV test-based coverage from screening of any kind, with 92% never having had the test that elimination modelling assumes. The gap matters to those costing cervical cancer elimination and modelling future incidence.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.
Other drivers in Health today
-
Cancer
Where is cancer incidence rising and falling, what screening and new tests find earlier, and what treatment has done to survival.
5 this week -
Obesity, diabetes and GLP-1
Are obesity and diabetes still rising, what behavioural change and public policy do, and what difference do GLP-1s and other similar drugs make.
2 this week -
Heart and stroke
Whether deaths from heart disease and stroke have stopped falling, what is found earlier, what treatment and prevention do now, and what the deaths say.
3 this week -
Mental health
Deaths by suicide, the life expectancy gap in severe mental illness, and the physical disease that follows it: what mental illness costs in lives.
1 this week -
Dementia
Whether dementia is becoming more or less common, what is now found, what treatment and prevention do, and what the deaths say.
3 this week -
Frailty and multimorbidity
Whether the years added after 85 are healthy ones, how frailty and multiple conditions are measured, and where the data run out.
1 this week
